Moreover, NAT10 is known to promote a more aggressive phenotype in HCC cells by inducing the EMT, as indicated by upregulation of mesenchymal markers such as E-cadherin and vimentin [14]. This evidence concerns the gene CDH1 and hepatocellular carcinoma.